Tallini G - Search Results

1

Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.

Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G. Garcia-Rostan G, et al. Among authors: tallini g. Am J Pathol. 2001 Mar;158(3):987-96. doi: 10.1016/s0002-9440(10)64045-x. Am J Pathol. 2001. PMID: 11238046 Free PMC article.

2

Oncocytic neoplasms of the thyroid gland.

Tallini G, Carcangiu ML, Rosai J. Tallini G, et al. Acta Pathol Jpn. 1992 May;42(5):305-15. doi: 10.1111/j.1440-1827.1992.tb02879.x. Acta Pathol Jpn. 1992. PMID: 1636432 Review.

3

Epithelioid angiosarcoma arising in uterine leiomyomas.

Tallini G, Price FV, Carcangiu ML. Tallini G, et al. Am J Clin Pathol. 1993 Nov;100(5):514-8. doi: 10.1093/ajcp/100.5.514. Am J Clin Pathol. 1993. PMID: 8249890

4

Combined morphologic and karyotypic study of 28 myxoid liposarcomas. Implications for a revised morphologic typing, (a report from the CHAMP Group).

Tallini G, Akerman M, Dal Cin P, De Wever I, Fletcher CD, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Van den Berghe H, Van den Ven W, Vanni R, Willen H. Tallini G, et al. Am J Surg Pathol. 1996 Sep;20(9):1047-55. doi: 10.1097/00000478-199609000-00002. Am J Surg Pathol. 1996. PMID: 8764741

5

Down-regulation of beta 1C integrin, an inhibitor of cell proliferation, in prostate carcinoma.

Fornaro M, Tallini G, Bofetiado CJ, Bosari S, Languino LR. Fornaro M, et al. Among authors: tallini g. Am J Pathol. 1996 Sep;149(3):765-73. Am J Pathol. 1996. PMID: 8780381 Free PMC article.

6

Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations.

Tallini G, Dal Cin P, Rhoden KJ, Chiapetta G, Manfioletti G, Giancotti V, Fusco A, Van den Berghe H, Sciot R. Tallini G, et al. Am J Pathol. 1997 Jul;151(1):37-43. Am J Pathol. 1997. PMID: 9212729 Free PMC article.

7

RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.

Tallini G, Santoro M, Helie M, Carlomagno F, Salvatore G, Chiappetta G, Carcangiu ML, Fusco A. Tallini G, et al. Clin Cancer Res. 1998 Feb;4(2):287-94. Clin Cancer Res. 1998. PMID: 9516913

8

Beta1C integrin in epithelial cells correlates with a nonproliferative phenotype: forced expression of beta1C inhibits prostate epithelial cell proliferation.

Fornaro M, Manzotti M, Tallini G, Slear AE, Bosari S, Ruoslahti E, Languino LR. Fornaro M, et al. Among authors: tallini g. Am J Pathol. 1998 Oct;153(4):1079-87. doi: 10.1016/s0002-9440(10)65652-0. Am J Pathol. 1998. PMID: 9777939 Free PMC article.

9

Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma.

Garcia-Rostan G, Tallini G, Herrero A, D'Aquila TG, Carcangiu ML, Rimm DL. Garcia-Rostan G, et al. Among authors: tallini g. Cancer Res. 1999 Apr 15;59(8):1811-5. Cancer Res. 1999. PMID: 10213482

10

Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization.

Tallini G, Hsueh A, Liu S, Garcia-Rostan G, Speicher MR, Ward DC. Tallini G, et al. Lab Invest. 1999 May;79(5):547-55. Lab Invest. 1999. PMID: 10334566

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters